Search Results - "Aroner, Sarah A"

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts by Jensen, Majken K, Aroner, Sarah A, Mukamal, Kenneth J, Furtado, Jeremy D, Post, Wendy S, Tsai, Michael Y, Tjønneland, Anne, Polak, Joseph F, Rimm, Eric B, Overvad, Kim, McClelland, Robyn L, Sacks, Frank M

“…BACKGROUND:The causal role of high-density lipoprotein (HDL) cholesterol in cardioprotection has been questioned by genetic and randomized studies. Novel…”
Get full text

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis) by Aroner, Sarah A., Koch, Manja, Mukamal, Kenneth J., Furtado, Jeremy D., Stein, James H., Tattersall, Matthew C., McClelland, Robyn L., Jensen, Majken K.

“…Background Apolipoprotein C‐III (apoC‐III), a small proinflammatory protein present on 6% to 7% of high‐density lipoprotein (HDL) particles, defines a…”
Get full text

Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies by Collins, Laura C., Aroner, Sarah A., Connolly, James L., Colditz, Graham A., Schnitt, Stuart J., Tamimi, Rulla M.

“…BACKGROUND Women with atypical hyperplasia (AH) on a benign breast biopsy specimen are at increased risk for the development of breast cancer. However, the…”
Get full text

HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study by Koch, Manja, Aroner, Sarah A., Fitzpatrick, Annette L., Longstreth, W.T., Furtado, Jeremy D., Mukamal, Kenneth J., Jensen, Majken K.

“…Whether HDL (high-density lipoprotein) is associated with risk of vascular brain injury is unclear. HDL is comprised of many apo (apolipoprotein) species,…”
Get full text

Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk by Aroner, Sarah A, Yang, Ming, Li, Junlong, Furtado, Jeremy D, Sacks, Frank M, Tjønneland, Anne, Overvad, Kim, Cai, Tianxi, Jensen, Majken K

“…Apolipoprotein C-III (apoC-III) is a potentially novel biomarker that may play an important role in the pathogenesis of diabetes, particularly when present on…”
Get full text

Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis by Aroner, Sarah A., Furtado, Jeremy D., Sacks, Frank M., Tsai, Michael Y., Mukamal, Kenneth J., McClelland, Robyn L., Jensen, Majken K.

“…Aims/hypothesis Apolipoprotein C-III (apoC-III) is a small proinflammatory protein that may play a key role in diabetes pathophysiology. However, prior…”
Get full text

Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis by Aroner, Sarah A, Mukamal, Kenneth J, St-Jules, David E, Budoff, Matthew J, Katz, Ronit, Criqui, Michael H, Allison, Matthew A, de Boer, Ian H, Siscovick, David S, Ix, Joachim H, Jensen, Majken K

“…Fetuin-A is a hepatic secretory protein and a novel risk factor for diabetes. However, it remains unclear whether the association between high levels of…”
Get full text

High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals by Yamamoto, Rain, Sacks, Frank M., Hu, Frank B., Rosner, Bernard, Furtado, Jeremy D., Aroner, Sarah A., Ferrannini, Ele, Baldi, Simona, Kozakova, Michaela, Balkau, Beverley, Natali, Andrea, Jensen, Majken K.

“…About 6–7% of high density lipoprotein (HDL) has a protein called apolipoprotein (apo) C-III that regulates lipoprotein metabolism and can provoke an…”
Get full text

Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies by Aroner, Sarah A., Collins, Laura C., Connolly, James L., Colditz, Graham A., Schnitt, Stuart J., Rosner, Bernard A., Hankinson, Susan E., Tamimi, Rulla M.

“…Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an…”
Get full text

Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis by Aroner, Sarah A, St-Jules, David E, Mukamal, Kenneth J, Katz, Ronit, Shlipak, Michael G, Criqui, Michael H, Kestenbaum, Bryan, Siscovick, David S, de Boer, Ian H, Jenny, Nancy S, Budoff, Matthew J, Ix, Joachim H, Jensen, Majken K

“…Abstract Aims Fetuin-A is a hepatic secretory protein that both promotes insulin resistance and inhibits arterial calcification. Previous studies have…”
Get full text

Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis by Morze, Jakub, Koch, Manja, Aroner, Sarah A, Budoff, Matthew, McClelland, Robyn L, Mukamal, Kenneth J, Jensen, Majken K

“…Previously, we reported that inverse associations of high-density lipoprotein (HDL) with cardiovascular disease and diabetes were only observed for HDL that…”
Get full text

New and Emerging Biomarkers in Cardiovascular Disease by Cahill, Leah E., Bertoia, Monica L., Aroner, Sarah A., Mukamal, Kenneth J., Jensen, Majken K.

“…Cardiovascular disease (CVD) is the most common cause of death and disability worldwide. Therefore, great importance has been placed on the discovery of novel…”
Get full text

Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health Study by Aroner, Sarah A., Rosner, Bernard A., Tamimi, Rulla M., Tworoger, Shelley S., Baur, Nadja, Joos, Thomas O., Hankinson, Susan E.

“…Purpose: Matrix metalloproteinases (MMPs), in particular MMP1, 3, and 7, are believed to be critical to breast cancer invasion and metastasis and also may have…”
Get full text

Columnar cell lesions and subsequent breast cancer risk: a nested case-control study by Aroner, Sarah A, Collins, Laura C, Schnitt, Stuart J, Connolly, James L, Colditz, Graham A, Tamimi, Rulla M

“…Histologic and genetic evidence suggests that at least some columnar cell lesions (CCL) of the breast represent precursor lesions in the low-grade breast…”
Get full text

Plasma matrix metalloproteinase 2 levels and breast cancer risk by Aroner, Sarah A, Rosner, Bernard A, Tamimi, Rulla M, Tworoger, Shelley S, Baur, Nadja, Joos, Thomas O, Hankinson, Susan E

“…Highlights • Pre-diagnostic plasma MMP2 was unassociated with total invasive breast cancer risk. • MMP2 was associated with an increased risk of nodal…”
Get full text

HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study by Koch, Manja, Aroner, Sarah A., Fitzpatrick, Annette L., Longstreth, W.T., Furtado, Jeremy D., Mukamal, Kenneth J., Jensen, Majken K.

Get full text

Breast cancer risk by extent and type of atypical hyperplasia: An update from the N urses' H ealth S tudies by Collins, Laura C., Aroner, Sarah A., Connolly, James L., Colditz, Graham A., Schnitt, Stuart J., Tamimi, Rulla M.

“…BACKGROUND Women with atypical hyperplasia (AH) on a benign breast biopsy specimen are at increased risk for the development of breast cancer. However, the…”
Get full text

HDL subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts by Jensen, Majken K., Aroner, Sarah A., Mukamal, Kenneth J., Furtado, Jeremy D., Post, Wendy S., Tsai, Michael Y., Tjønneland, Anne, Polak, Joseph F., Rimm, Eric B., Overvad, Kim, McClelland, Robyn L., Sacks, Frank M.

Get full text

Abstract MP45: Liver Fat Content Does Not Account for the Strong Association of Fetuin-A with Diabetes Risk in Women: The Multi-Ethnic Study of Atherosclerosis by Aroner, Sarah A, Mukamal, Kenneth J, St-Jules, David E, Budoff, Matthew J, Katz, Ronit, Criqui, Michael H, Allison, Matthew A, de Boer, Ian H, Siscovick, David S, Ix, Joachim H, Jensen, Majken K

“…Abstract only Introduction: Fetuin-A, a hepatic secretory protein, has been associated with risk of diabetes. However, liver fat content may be an important…”
Get full text

Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study by Spanogle, Joshua P., MD, Clarke, Christina A., PhD, MPH, Aroner, Sarah, BA, Swetter, Susan M., MD

“…Background Understanding risk patterns for developing a second primary malignancy (SPM) after cutaneous melanoma (CM) has implications for both research and…”
Get full text